Akkaraju Srinivas (CIK 0001253170)

Latest company ownership

Shares held
5,674,916
Last filed at
Mar 17, 2025
Confidence Score
60.0
2025Q4
Confidence Score History
2023Q1 2025Q4
ALMS - ALUMIS INC.
Role: Director
Shares held
5,504,580
Last filed at
Dec 4, 2025
Confidence Score
89.6
2025Q4
Confidence Score History
2024Q3 2025Q4
Shares held
5,323,942
Last filed at
Oct 7, 2025
Confidence Score
87.4
2025Q4
Confidence Score History
2023Q4 2025Q4
MEIP - MEI Pharma, Inc.
Role: 10% Owner
Shares held
2,502,775
Last filed at
Feb 20, 2013
Confidence Score
50.0
2025Q4
Confidence Score History
2013Q1 2025Q4
NGNE - Neurogene Inc.
Role: 10% Owner
Shares held
1,717,127
Last filed at
Nov 27, 2024
Confidence Score
50.1
2025Q4
Confidence Score History
2024Q4 2025Q4
ATYR - aTYR PHARMA INC
Role: Director
Shares held
1,546,126
Last filed at
May 14, 2015
Confidence Score
50.0
2025Q4
Confidence Score History
2015Q2 2025Q4
Shares held
598,002
Last filed at
Oct 13, 2015
Confidence Score
50.0
2025Q4
Confidence Score History
2015Q4 2025Q4
SYBX - SYNLOGIC, INC.
Role: 10% Owner
Shares held
583,559
Last filed at
Oct 6, 2015
Confidence Score
50.0
2025Q4
Confidence Score History
2015Q4 2025Q4
Shares held
22,753
Last filed at
Jul 1, 2021
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q2 2025Q4
OCGN - Ocugen, Inc.
Role: 10% Owner
Shares held
14,569
Last filed at
Dec 10, 2014
Confidence Score
50.0
2025Q4
Confidence Score History
2014Q4 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Oct 7, 2025 Dec 16, 2025 Scholar Rock Holding Corp Director Buy 95.0 +29,599 5.67% ✗ $1.2M
Dec 5, 2025 Dec 9, 2025 ALUMIS INC. Director Buy 92.5 +186,377 3.35% ✗ $1.8M
Dec 2, 2025 Dec 4, 2025 ALUMIS INC. Director Buy 92.5 +262,027 4.94% ✗ $2M
Nov 26, 2025 Dec 1, 2025 ALUMIS INC. Director Buy 92.5 +173,589 3.38% ✗ $1.3M
Nov 20, 2025 Nov 24, 2025 ALUMIS INC. Director Buy 90.0 +125,743 2.51% ✗ $905.3K
Nov 17, 2025 Nov 19, 2025 ALUMIS INC. Director Buy 95.0 +241,338 5.06% ✗ $1.5M
Nov 13, 2025 Nov 17, 2025 ALUMIS INC. Director Buy 95.0 +276,179 6.15% ✗ $1.4M
Oct 3, 2025 Oct 7, 2025 Scholar Rock Holding Corp Director Buy 97.5 +500,439 9.40% ✗ $18.8M
Sep 4, 2025 Sep 8, 2025 Mineralys Therapeutics, Inc. Director Buy 100.0 +588,235 10.37% ✗ $15M
May 2, 2025 May 6, 2025 ALUMIS INC. Director Buy 95.0 +320,290 9.81% ✗ $1.5M
Mar 13, 2025 Mar 17, 2025 Mineralys Therapeutics, Inc. Director Buy 100.0 +600,000 11.82% ✗ $8.1M
Nov 26, 2024 Nov 27, 2024 Neurogene Inc. 10% Owner Buy 92.5 +48,770 2.92% ✗ $1.3M
Oct 7, 2024 Oct 7, 2024 Scholar Rock Holding Corp Director Sell 21.3 -1,175,713 -8.99% ✓ $34.4M
Jul 1, 2024 Aug 27, 2024 ALUMIS INC. Director Buy 100.0 +1,562,500 91.70% ✗ $25M
Oct 16, 2023 Oct 18, 2023 Scholar Rock Holding Corp Director Buy 100.0 +2,189,781 47.62% ✗ $15M
Feb 14, 2023 Feb 16, 2023 Mineralys Therapeutics, Inc. Director Buy 100.0 +937,500 26.17% ✗ $15M
Apr 11, 2022 Apr 13, 2022 LENZ Therapeutics, Inc. 10% Owner Buy 95.0 +424,464 5.26% ✗ $1.7M
Jan 21, 2022 Jan 25, 2022 LENZ Therapeutics, Inc. 10% Owner Buy 87.5 +123,000 1.55% ✗ $1.1M
Jan 19, 2022 Jan 21, 2022 LENZ Therapeutics, Inc. 10% Owner Buy 85.0 +97,670 1.25% ✗ $888.7K
Dec 15, 2021 Dec 20, 2021 LENZ Therapeutics, Inc. 10% Owner Buy 65.0 +22,329 0.29% ✗ $227.5K
Nov 22, 2021 Nov 24, 2021 LENZ Therapeutics, Inc. 10% Owner Buy 92.5 +201,685 2.66% ✗ $2M
Oct 13, 2021 Oct 15, 2021 LENZ Therapeutics, Inc. 10% Owner Buy 75.0 +50,800 0.67% ✗ $667.7K
Oct 6, 2021 Oct 8, 2021 LENZ Therapeutics, Inc. 10% Owner Buy 87.5 +145,496 1.97% ✗ $2M
Jun 29, 2021 Jul 1, 2021 LENZ Therapeutics, Inc. 10% Owner Buy 96.3 +500,000 7.21% ✗ $8.5M
Oct 13, 2015 Oct 13, 2015 Aclaris Therapeutics, Inc. 10% Owner Buy 100.0 +409,090 21.76% ✗ $4.5M
Oct 5, 2015 Oct 6, 2015 SYNLOGIC, INC. 10% Owner Buy 100.0 +1,146,983 62.75% ✗ $6M
May 12, 2015 May 14, 2015 aTYR PHARMA INC Director Buy 100.0 +320,000 20.70% ✗ $4.5M
Dec 8, 2014 Dec 10, 2014 Ocugen, Inc. 10% Owner Buy 100.0 +490,388 30.91% ✗ $5.5M
Feb 15, 2013 Feb 20, 2013 MEI Pharma, Inc. 10% Owner Sell 17.5 -497,225 -16.57% ✗ $3.3M